Serum Proteomics Hint at an Early T-cell Response and Modulation of SARS-CoV-2-related Pathogenic Pathways in COVID-19-ARDS Treated with Ruxolitinib.
FRONTIERS IN MEDICINE(2023)
关键词
acute respiratory distress syndrome,COVID-19,proteomics,Ruxolitinib,SARS-CoV-2
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要